Literature DB >> 27888162

Photodynamic therapy as an alternative treatment for relapsed or refractory mycosis fungoides: A systemic review.

Jingwen Xue1, Cynthia Liu2, Yuehua Liu3.   

Abstract

Mycosis fungoides is the most common cutaneous T-cell lymphoma. It is characterized by slow progress over years to decades, developing from patches to infiltrated plaques, and sometimes to tumors. Therapies such as localized chemotherapy, photochemotherapy and radiotherapy are often employed when lesions of refractory or relapsing mycosis fungoides are resistant to conventional therapies. However, these methods have acute or chronic side effects and toxicity, which may accumulate with repeated and protracted treatment cycles. Photodynamic therapy is a promising, well-tolerated option for the treatment of localized lesions with excellent cosmetic outcomes. In this article, we systematically reviewed and discussed clinical application of photodynamic therapy in relapsed or refractory mycosis fungoides. There are 20 papers included in this review article.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Aminolevulinic acid; Methyl aminolevulinic acid; Photodynamic therapy; Relapsed or refractory mycosis fungoides

Mesh:

Substances:

Year:  2016        PMID: 27888162     DOI: 10.1016/j.pdpdt.2016.11.010

Source DB:  PubMed          Journal:  Photodiagnosis Photodyn Ther        ISSN: 1572-1000            Impact factor:   3.631


  3 in total

1.  An insight into photodynamic therapy towards treating major dermatological conditions.

Authors:  Anuradha Dey; Gautam Singhvi; Anu Puri; Prashant Kesharwani; Sunil Kumar Dubey
Journal:  J Drug Deliv Sci Technol       Date:  2022-08-30       Impact factor: 5.062

Review 2.  Sensitive Photodynamic Detection of Adult T-cell Leukemia/Lymphoma and Specific Leukemic Cell Death Induced by Photodynamic Therapy: Current Status in Hematopoietic Malignancies.

Authors:  Takashi Oka; Ken-Ichi Matsuoka; Atae Utsunomiya
Journal:  Cancers (Basel)       Date:  2020-02-02       Impact factor: 6.639

3.  Metabolic abnormalities in adult T-cell leukemia/lymphoma and induction of specific leukemic cell death using photodynamic therapy.

Authors:  Takashi Oka; Hajime Mizuno; Masumi Sakata; Hirofumi Fujita; Tadashi Yoshino; Yoshihisa Yamano; Kozo Utsumi; Tsutomu Masujima; Atae Utsunomiya
Journal:  Sci Rep       Date:  2018-10-08       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.